Nath Bio-Genes (India) Limited (BOM:537291)

India · Delayed Price · Currency is INR

138.95

+4.75 (3.54%)

At close: Oct 6, 2026

Market Cap	2.63B -17.1%
Revenue (ttm)	4.90B +21.0%
Net Income	456.11M +7.3%
EPS	22.99 +2.9%
Shares Out	n/a
PE Ratio	5.76
Forward PE	n/a
Dividend	2.00 (1.44%)
Ex-Dividend Date	Sep 11, 2026

Volume	1,684
Open	134.00
Previous Close	134.20
Day's Range	134.00 - 139.65
52-Week Range	126.75 - 207.00
Beta	n/a
Analysts	n/a
Price Target	n/a
Est. Earnings	Oct 29, 2026

About Nath Bio-Genes (India)

Nath Bio-Genes (India) Limited engages in the production, processing, and marketing of hybrid and GM seeds in India and internationally. It operates in two segments, Agricultural Activities and Trading Activities. The company offers fiber and oil seeds, including cotton and mustard; fruit seeds, which includes Rustam +, Rustam, Mukhiya, and Ranjit; seeds for field crops, such as bajra, corn, paddy, wheat, and jowar; and seeds for vegetables comprising cabbage, French beans, chili, onion, okra, tomato, brinjal, bottle gourd, bitter gourd, corian... [Read more]

Industry Agricultural Production Crops

Founded 1979

Employees 452

Stock Exchange Bombay Stock Exchange

Ticker Symbol 537291

Full Company Profile

Financial Performance

In fiscal year 2026, Nath Bio-Genes (India)'s revenue was 4.45 billion, an increase of 21.95% compared to the previous year's 3.65 billion. Earnings were 416.30 million, an increase of 7.85%.

Financial Statements